Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.71% |
| 2 | Healthcare | 14.72% |
| 3 | Consumer Discretionary | 14.64% |
| 4 | Industrials | 11.02% |
| 5 | Consumer Staples | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPAI
2126
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $179K | ﹤0.01% |
17,077
-14,276
| -46% | -$146K |
|
|
LITS
2127
Lite Strategy Inc
LITS
$33.7M
| $170K | ﹤0.01% |
2,481
| – | – |
|
2128
Amcor
AMCR
$22.5B
| $168K | ﹤0.01% |
2,917
-40,553
| -93% | -$2.31M |
|
2129
Mustang Bio
MBIO
$4.39M
| $168K | ﹤0.01% |
+67
| New | +$199K |
|
2130
RLJ Lodging Trust
RLJ
$1.75B
| $164K | ﹤0.01% |
+10,596
| New | +$158K |
|
|
CKPT
2131
DELISTED
Checkpoint Therapeutics
CKPT
| $162K | ﹤0.01% |
+5,160
| New | +$173K |
|
|
FPI
2132
Farmland Partners
FPI
$443M
| $161K | ﹤0.01% |
+14,377
| New | +$164K |
|
2133
Transocean
RIG
$6.61B
| $159K | ﹤0.01% |
+44,679
| New | +$155K |
|
2134
CEL-SCI Corp
CVM
$25M
| $157K | ﹤0.01% |
344
-331
| -49% | -$181K |
|
2135
PAVmed
PAVM
$41.3M
| $157K | ﹤0.01% |
78
-107
| -58% | -$161K |
|
2136
Rigel Pharmaceuticals
RIGL
$857M
| $157K | ﹤0.01% |
4,599
-345
| -7% | -$13.7K |
|
2137
Radiant Logistics
RLGT
$395M
| $152K | ﹤0.01% |
+21,911
| New | +$145K |
|
|
SYRS
2138
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $147K | ﹤0.01% |
1,967
-723
| -27% | -$75.1K |
|
|
WOW
2139
DELISTED
WideOpenWest
WOW
| $142K | ﹤0.01% |
+10,422
| New | +$137K |
|
2140
Genprex
GNPX
$3.24M
| $141K | ﹤0.01% |
1
-1
| -50% | -$220K |
|
2141
Greenlane Holdings
GNLN
$2.05M
| – | – |
0
| – | – |
|
2142
RPC Inc
RES
$1.41B
| $138K | ﹤0.01% |
25,504
-18,148
| -42% | -$92K |
|
2143
Akebia Therapeutics
AKBA
$251M
| $133K | ﹤0.01% |
39,248
-160,845
| -80% | -$579K |
|
|
SEI
2144
Solaris Energy Infrastructure
SEI
$3.51B
| $132K | ﹤0.01% |
+10,760
| New | +$123K |
|
2145
Cerus
CERS
$566M
| $129K | ﹤0.01% |
21,421
+5,765
| +37% | +$39.2K |
|
2146
NovaGold Resources
NG
$3.83B
| $128K | ﹤0.01% |
14,572
-55,460
| -79% | -$506K |
|
|
PVLA
2147
Palvella Therapeutics
PVLA
$2.05B
| $126K | ﹤0.01% |
612
-620
| -50% | -$136K |
|
2148
Gyre Therapeutics
GYRE
$733M
| $121K | ﹤0.01% |
3,188
| – | – |
|
|
GTT
2149
DELISTED
GTT Communications, Inc.
GTT
| $120K | ﹤0.01% |
65,776
+46,662
| +244% | +$142K |
|
|
CBD
2150
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $113K | ﹤0.01% |
+19,498
| New | +$236K |
|
Similar funds
Cliff Asness's Q1 2021 Portfolio in Review
As of Q1 2021, Cliff Asness held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cliff Asness's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Cliff Asness's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- Cliff Asness added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- Cliff Asness's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- Cliff Asness fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- Cliff Asness's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- Cliff Asness opened 154 new positions and closed 154 in Q1 2021.
- Cliff Asness's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.